Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-09-057145
Filing Date
2009-09-30
Accepted
2009-09-30 21:00:26
Documents
2
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3691
2 EX-24 ex-24.htm EX-24 7803
  Complete submission text file 0001104659-09-057145.txt   13292
Mailing Address 26110 ENTERPRISE WAY STE 200 LAKE FOREST CA 92630
Business Address
MAYER STEVEN F (Reporting) CIK: 0001280289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34473 | Film No.: 091096896

Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Issuer) CIK: 0001405197 (see all company filings)

EIN.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations